Sumiyoshi, I.; Togo, S.; Okabe, T.; Abe, K.; Watanabe, J.; Ochi, Y.; Hoshi, K.; Saiwaki, S.; Nojiri, S.; Fujimoto, Y.;
et al. Dynamics of Telomerase-Based PD-L1 Circulating Tumor Cells as a Longitudinal Biomarker for Treatment Response Prediction in Patients with Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2025, 26, 9583.
https://doi.org/10.3390/ijms26199583
AMA Style
Sumiyoshi I, Togo S, Okabe T, Abe K, Watanabe J, Ochi Y, Hoshi K, Saiwaki S, Nojiri S, Fujimoto Y,
et al. Dynamics of Telomerase-Based PD-L1 Circulating Tumor Cells as a Longitudinal Biomarker for Treatment Response Prediction in Patients with Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2025; 26(19):9583.
https://doi.org/10.3390/ijms26199583
Chicago/Turabian Style
Sumiyoshi, Issei, Shinsaku Togo, Takahiro Okabe, Kanae Abe, Junko Watanabe, Yusuke Ochi, Kazuaki Hoshi, Shoko Saiwaki, Shuko Nojiri, Yuichi Fujimoto,
and et al. 2025. "Dynamics of Telomerase-Based PD-L1 Circulating Tumor Cells as a Longitudinal Biomarker for Treatment Response Prediction in Patients with Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 26, no. 19: 9583.
https://doi.org/10.3390/ijms26199583
APA Style
Sumiyoshi, I., Togo, S., Okabe, T., Abe, K., Watanabe, J., Ochi, Y., Hoshi, K., Saiwaki, S., Nojiri, S., Fujimoto, Y., Namba, Y., Tabe, Y., Urata, Y., & Takahashi, K.
(2025). Dynamics of Telomerase-Based PD-L1 Circulating Tumor Cells as a Longitudinal Biomarker for Treatment Response Prediction in Patients with Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 26(19), 9583.
https://doi.org/10.3390/ijms26199583
